Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma
一项针对复发/难治性弥漫性大B细胞淋巴瘤患者的阿伐多米德（CC-122）、CC-223、CC-292和利妥昔单抗联合治疗的Ib期研究
期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.375
Ribrag, Vincent; Chavez, Julio C; Boccomini, Carola; Kaplan, Jason; Chandler, Jason C; Santoro, Armando; Corradini, Paolo; Flinn, Ian W; Advani, Ranjana; Cassier, Philippe A; Sangha, Randeep; Kenkre, Vaishalee P; Isufi, Iris; Uttamsingh, Shailaja; Hagner, Patrick R; Gandhi, Anita K; Shen, Frank; Michelliza, Sophie; Haeske, Harald; Hege, Kristen; Pourdehnad, Michael; Kuruvilla, John
